Tg Therapeutics Inc (TGTX)

Cash & Equivalents

$482.58M

Quarterly · Period ending: · USD

TGTX logo

TGTX Cash & Equivalents

Latest reported$482.58M
TGTX Quarterly Cash & Equivalents ($2.80M → $482.58M)
High-resolution chart · PNG

TGTX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
482,575,000
442,209,000
79,148,000
74,081,000
129,126,000
132,139,000
179,894,000
195,822,000
82,910,000
75,477,000
92,933,000
150,902,000
97,009,000
61,469,000
102,304,000
109,860,000
147,073,000
185,676,000
298,887,000
326,512,000
401,707,000
471,514,000
553,439,000
254,154,000
260,512,000
52,051,000
112,637,000
44,675,000
57,228,000
64,349,000
41,958,000
70,718,000
105,672,000
82,896,000
56,717,847
91,842,167
77,602,363
95,637,572
25,031,280
29,156,521
28,577,832
36,478,420
55,061,329
65,461,940
60,300,086
86,004,445
55,713,784
53,225,799
37,077,977
49,596,327
40,485,466
50,183,397
13,416,952
15,188,167
16,455,995
17,373,866
20,367,079
20,923,750
9,748,491
212,280
492,508
591,316
478,668
1,075,966
1,572,031
2,017,280
17,996
153,641
294,568
230,496
106,023
35,664
576,354
1,133,124
649,686
2,032,655
4,790,589
8,689,792
3,029,118
3,912,684
6,045,287
8,532,374
9,826,336
11,868,808
889,864
544,951
905,656
7,408,879
8,865,578
9,543,071
7,413,803
102,114
477,863
1,146,600
116,291
375,845
445,375
933,225
1,591,761
440,558
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.